ARWR - Arrowhead Pharmaceuticals • Financials

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.

Complete and updated financials table with all primary indicators: Net Income, Revenue, EBITDA, Margin, ROE, Dividends

Year	Revenue	EBITDA	Net Inc	Net Mrg	EPS	Equity	ROE	Net Debt Aj	ND/EBITDA Aj	OCF Aj	Capex	FCF	Free Aj	Buyback	Dividend	Payout	DY
09/2016	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
09/2017	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
09/2018	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
09/2019	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
09/2020	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
09/2021	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
09/2022	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
09/2023	241	-193	-	L	L	271	L	-135	-	-232	-177	253	-409	0	0	-	-
09/2024	4	-582	-	L	L	183	L	80	L	-537	-141	871	-678	0	0	-	-
09/2025	829	122	-	L	L	466	L	-159	-	116	-23	74	94	0	0	-	-

To see all financials—including updated, you must be Premium.